Moyamoya disease - Diagnosis and treatment: Indirect cerebral revascularization at the Sheba Medical Center

Israel Medical Association Journal

Volumn 7, Issue 10, 2005, Pages 661-666

  Nissim, Ouzi ^a,b   Bakon, Mati ^a,b   Zeev, Bruria Ben ^a,b   Goshen, Elinor ^a,b   Knoller, Nachshon ^a,b   Hadani, Moshe ^a,b   Feldman, Zeev ^a,b  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Angiography; Cerebral ischemia; Cerebral revascularization; Moyamoya; Subarachnoid hemorrhage

Indexed keywords

ANTITHROMBOCYTIC AGENT; CALCIUM CHANNEL BLOCKING AGENT;

BRAIN ANGIOGRAPHY; BRAIN BLOOD VESSEL; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; BYPASS SURGERY; DIAGNOSTIC PROCEDURE; ENVIRONMENTAL EXPOSURE; FAR EAST; GENETIC DISORDER; HEREDITY; HUMAN; ISRAEL; MEDICAL LITERATURE; MICROSURGERY; MOYAMOYA DISEASE; NON INVASIVE MEASUREMENT; PATHOGENESIS; REVIEW; STENOSIS;

ADULT; CEREBRAL REVASCULARIZATION; CHILD; FEMALE; HUMANS; ISRAEL; MALE; MOYAMOYA DISEASE;

EID: 27144524220     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. Komiyama M, Nishikawa M, Yasui T, Kitao S, Sakamoto H, Fu Y. Steno-occlusive changes in the external carotid system in Moyamoya disease. Acta Neurochir (Wien) 2000;142:421-4.
2. Kudo T. Spontaneous occlusion of the circle of Willis. A disease apparently confined to Japanese. Neurology 1968;18:485-6.
3. Suzuki J, Takaku A. Cerebrovascular Moyamoya disease: disease showing abnormal net-like vessels in base of brain. Arch Neurol 1969;20:288-99.
4. Wetjen NM, Garell C, Stence NV, Loftus C. Moyamoya disease in the midwestern United States. Neurosurg Focus 1998;5:5,E1.
5. Ikeda H, Sasaki T, Yoshimoto T, et al. Mapping of a familial Moyamoya disease gene to chromosome 3p24.2-p.26. Am J Hum Genet 1999;64:533-7.
6. Ymauchi T, Tada M, Houkin K, et al. Linkage of familial Moyamoya disease (spontaneous occlusion of the circle of Willis) to chromosome 17 25. Stroke 2000;31:930-5.
7. Inuoe TK, Ikezaki K, Sasazuki T, Matsushima T, Fufui M. Linkage analysis of Moyamoya disease on chromosome 6. J Child Neurol 2000;15:179-82.
8. El Ramahi KM, Al Rayes HM. Systemic lupus erythematosus associated with Moyamoya syndrome. Lupus 2000;9:632-6
9. Terajina K, Shimohata T, Watanabe M, et al. Cerebral vasculopathy showing Moyamoya-like changes in a patient with CREST syndrome. Eur Neurol 2001;46:163-5.
10. Rodrigues-Jadraque R, Martinez-Salio A, Garcia de alvaro MT, et al. Arterio venous malformations in neurofibromatosis type 1. A case report and review of the literature. Rev Neurol 2000;31:1043-5.
11. Dai AI, Shaikh ZA, Cohen ME. Early-onset Moyamoya syndrome in a patient with Down syndrome: case report and review of the literature. J Child Neurol 2000;15:696-9.
12. Bonduel M, Hepner M, Sciuccati G, Torres AF, Tenembaum S. Prothrombotic disorders in children with Moyamoya syndrome. Stroke 2001;32:1786-92.
13. Miruyama K, Mishima K, Siato N, Fujimaki T, Sasaki T, Kirino T. Radiation-induced aneurysm and Moyamoya vessels presenting with subarachnoid hemorrhage. Acta Neurochir (Wien) 2000;142:139-43.
14. Storen EC, Wejdicks EF, Crum BA, Schultz G. Moyamoya-like vasculopathy from cocaine dependency. Am J Neuoradiol 2000;21:1008-10.
15. Han DH, Kwon OK, Byun BJ, et al. A co-operative study: clinical characteristics of 334 Korean patients with Moyamoya disease treated at neurosurgical institutes (1976-1994). The Korean Society for Cerebrovascular Disease. Acta Neurochir (Wien) 2000;142:1263-74.
16. Mootha SL, Riley WJ, Brosnan PG. Hypothalamic-pituitary dysfunction associated with Moyamoya disease in children. J Pediatr Endocrinol Metab 1999;12:449-53.
17. Yoshida Y, Yoshioto T, Shirane R, Sakurai Y. Clinical course, surgical management and long term outcome of Moyamoya patients with rebleeding after an episode of intracerebral hemorrhage: an extensive follow-up study. Stroke 1999;30:2272-6.
18. Kobayashi E, Saeki N, Oishi H, Hirai S, Yamaura A. Long term natural history of hemorrhagic Moyamoya disease in 42 patients. J Neurosurg 2000;93:976-80.
19. Fukui M, Kono S, Sueishi K, Ikezaki K. Moyamoya disease. Neuropathology 2000;20(Suppl):S61-4
20. Yamada I, Himeno Y, Matsushima Y, Shibuya H. Renal artery lesions in patients with Moyamoya disease: angiographic findings. Stroke 2000;31:733-7.
21. Houkin K, Yoshimoto T, Abe H, et al. Role of basic fibroblast growth factor in the pathogenesis of moyamoya disease. Neurosurg Focus 1998;5:5E2.
22. Soriano SG, Cowan DB, Proctor MR, Scott RM. Levels of soluble adhesion molecules are elevated in the cerebrospinal fluid of children with Moyamoya syndrome. Neurosurgery 2000;50:544-9
23. Yoon HK, Shin HJ, Lee M, Byun HS, Na DG, Han BK. MR angiography of Moyamoya disease before and after encephaloduroarteriosynangiosis. Am J Roentgenol 2000;174:195-200.
24. Calamante F, Ganesan V, Kirkham FJ, Jan W, Chong WK, Gadian DG, Connely A. MR perfusion studies in Moyamoya syndrome: potential implications for clinical evaluation for clinical evaluation of occlusive cerbrovascular disease. Stroke 2001;32:2810-16.
25. Khan N, Shuknecht B, Boltshauser E, et al. Moyamoya disease and Moyamoya syndrome: experience in Europe; choice of revascularization procedures. Acta Neurochir (Wien) 2003;145:1061-71.
26. Liu HM, Peng SS, Li YW. The preoperative and postoperative cerebral blood flow and vascularity in childhood Moyamoya disease. Kieio J Med 2000;49(Suppl 1):86-9.
27. Ipsiroglu OS, Eichler F, Stockler-Ipsiroglu S, Tratting S. Cerebral blood flow velocities in an infant with Moyamoya disease. Pediatr Neurol 1999;21:739-41.
28. Harada M, Mioshi H, Uno M, et al. Neuronal impairment in adult moyamoya disease detected by quantified proton MRS and comparison with cerebral perfusion by SPECT with Tc-99m HM-PAO: a trial of clinical quantification of metabolites. J Magn Reson Imaging 1999;10:124-9.
29. Imaizumi C, Imaizumi T, Osawa M, Fukutama Y, Takeshita M. Serial intelligence scores in pediatric Moyamoya disease. Neuropediatrics 1999;30:294-9.
30. Fung LW, Thompson D, Ganesan V. Revascularization for pediatric moyamoya; a review of the literature. Childs Nerv System 2005;21:358-64.
31. Ikezaki K. Rational approach to treatment of moyamoya disease in childhood. J Child Neurol 2000;15:350-6.
32. Kawaguchi S, Okuono S, Skaki T. Effect of direct arterial bypass on the prevention of future stroke in patients with the hemorrhagic variety of Moyamoya disease. J Neurosurg 2000;93:397-401.
33. Golby AJ, Marks MP, Thompson RC, Steinberg GK. Direct and combined revascularization in pediatric Moyamoya disease. Neurosurgery 1999;45:50-8.
34. Houkin K, Kuroda S, Nakayama N. Cerebral revascularization for moyamoya disease in children. Neurosurg Clin North Am 2001;12:575-84.
35. Matsuhshima T, Fujiwara S, Nagata S, et al. Surgical treatment of pediatric patients with Moyamoya disease by indirect revascularization procedures (EDAS, EMS, EMAS). Acta Neurochir (Wien) 1989;98:135-40.
36. Dauser RC, Tuite GF, McCluggage CW. Dural inversion procedure for Moyamoya disease. Technical note. J Neurosurg 1997;86:719-23.
37. Kim SK, Wang KC, Kim IO, Lee DS, Cho BK. Combined encephaloduroarteriosynangiosis and bifrontal encephlogaleo (periosteal) synangiosis in pediatric Moyamoya disease. Neurosurgery 2002;50:88-96.
38. Irikura K, Miyasaka Y, Kurata A, et al. The effects of encephalomyo-synangiosis on abnormal collateral vessels in childhood Moyamoya disease. Neurol Res 2000;22:341-6.
39. Houkin K, Kuroda S, Ishikawa T, Abe H. Neovascularization (angiogenesis) after revascularization in Moyamoya disease. Which technique is most useful for Moyamoya disease? Acta Neurochir (Wien) 2000;142:269-76.
40. Kuroda S, Houkin K, Kimiyama H, Abe H. Effects of surgical revascularization on peripheral artery aneurysms in Moyamoya disease: report of three cases. Neurosurgery 2001;49:463-7.